Acceleritas Corp (ALZH) 0.1261 $ALZH
Hollywall
Acceleritas Corp (ALZH) 0.1261 $ALZH
Hollywall Entertainment, Inc. Announces the Acquisition of Crazy For the Boys, LLC and its First Major Motion Picture Production
ACCESSWIRE - Mon Sep 08, 11:17AM CDT
NASHVILLE, TN / ACCESSWIRE / September 8, 2014 / Hollywall Entertainment, Inc. (OTC Pink: ALZH) (PINKSHEETS: ALZH) has agreed to acquire Crazy for the Boys, LLC.
Hollywall Entertainment, Inc. Announces the appointment of Charlie Springer as President of Hollywall Music Group
ACCESSWIRE - Tue Sep 02, 3:00PM CDT
Nashville, TN / ACCESSWIRE / September 2, 2014 / Hollywall Entertainment, Inc., (OTC: ALZH ) announces the appointment of Charlie Springer as President of its Hollywall Music Group.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
So here’s the scoop: Rate just teamed up with Betterment on February 17, 2026, offering some pretty slick mortgage incentives for those sitting on at least $100K in their investment accounts. But let’s dig into the nitty-gritty before you start dreaming of that low-rate home loan. Betterment's Strategy: Solid Gains or Hype? The partnership aims to deliver discounted...
Continue Reading
Morgan Stanley Highlights UK Water Sector Improvements Investment risks surrounding listed UK water companies have significantly decreased following a key regulatory decision concerning water bill increases in England and Wales. According to analysts from Morgan Stanley, this development has created a more favorable landscape for investors in the sector. Key Insights From...
Continue Reading
SiLC Technologies Introduces Eyeonic Trace Laser Line Scanner SiLC Technologies, a leader in the development of advanced integrated FMCW LiDAR solutions, recently announced an exciting new product: the Eyeonic Trace Laser Line Scanner. This state-of-the-art Class 1 Laser Line Scanner is engineered to achieve precise measurements of objects from distances of up to 10...
Continue Reading
Accord BioPharma Announces FDA Approval for HERCESSI™ Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has achieved a major milestone in cancer treatment with the FDA's approval of a new 420mg strength of HERCESSI™ (trastuzumab-strf). This biosimilar to Herceptin (trastuzumab) targets different types of HER2-overexpressing cancers, such as...
Continue Reading
What’s Driving Oklo Inc’s Stock Surge? Oklo Inc (NYSE: OKLO) is making waves in the stock market as its shares witness impressive growth. Over the past month, the company has experienced a remarkable rally of approximately 60%. Investors are keen to learn about the driving forces behind this upward trend. Recent Positive Developments This recent surge can primarily be...
Continue Reading